Company / Current Assets
NewAmsterdam Pharma Co N.V. Current Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$675.7M
FY2025
5-year range
$346.8M / $863.4M
FY2022-FY2025
Trend
-21.7%
vs FY2024
Sector context
#88 of 214
Health Care
What the data says
At $676M, NewAmsterdam Pharma Co N.V.'s current assets ranks #88 of 214 in the Health Care sector. Improved from $347M to $676M over the past 2 years.
Based on SEC 10-K filings.
$676M in FY2025 with a 3-year CAGR of +12.2%.
Improved from $347M to $676M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +12.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#88 of 214 in Health CareTop 41% of 214This company $675.7M Sector average $2.5B
▼
-73.3% below sector average
Key checks
Key Insights
- 3-year CAGR of +12.2%, indicating consistent growth.
- In FY2025, current assets decreased 21.7% year-over-year.
- Ranks #88 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $675.7M | -21.7% |
| FY2024 | $863.4M | +149.0% |
| FY2023 | $346.8M | -27.4% |
| FY2022 | $478.0M | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026